Metabolic alterations in multiple myeloma and extramedullary disease- a novel niche of therapeutic targets
{{output}}
Metabolic reprogramming is a hallmark of cancer, actively contributing to tumour growth and therapeutic resistance. Multiple myeloma (MM) is a common haematological malignancy that exhibits distinct metabolic features, while Extramedullary Myeloma Disease (EMD... ...
